Peter Clemmensen, ESC 2020 – the New ESC Guidelines for N-STEMI
We caught up with Professor Peter Clemmensen (University Heart Center Hamburg, Hamburg, Germany) to discuss the recent ESC Guidelines update for non-ST elevation myocardial infarction (N-STEMI) and how these may affect outcomes and clinical practice.
- What are the major unmet needs in the management of acute myocardial infarction in patients presenting without ST-segment elevation? (0.22)
- How do non-ST elevation myocardial infarction (N-STEMI) outcomes vary across Europe? (1.31)
- Could you give us an overview of what’s new in the guidelines? (2.35)
- What will be the major impact of these guidelines on clinical practice? (5.40)
- What practical advice would you like to share with physicians managing N-STEMI in their patients? (7.00)
Speaker disclosures: Professor Peter Clemmensen has previously or currently been involved in research contracts, consulting, speakers bureau or received research and educational grants from Abbott, AstraZeneca, Aventis, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Eli-Lilly, Evolva, Fibrex, Janssen, Merck, Myogen, Medtronic, Mitsubishi Pharma, The Medicines Company, Nycomed, Organon, Pfizer, Pharmacia, Regado, Sanofi, Searle, Servier and ViFor Pharma.
Support: Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Professor Peter Clemmensen, September 2020.
Share this Video
Related Videos In Cardiovascular Disease
John Forrest, ACC 2023: Evolut low risk trial, transcatheter versus surgical aortic valve replacement in patients at low surgical risk
The Evolut low risk trial aimed to compare transcatheter versus surgical aortic valve replacement in patients who were at low risk for surgery. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to discuss the eligibility criteria, the key findings and the outlook for […]
John Forrest, ACC 2023: The treatment paradigm for patients with aortic stenosis
The treatment paradigm for aortic stenosis has developed dramatically in the past decade. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to outline and discuss the developments. Dr Forrest presented an abstract entitled ‘Transcatheter Versus Surgical Aortic Valve Replacement In Aortic Stenosis Patients […]
Steven Nissen, ACC 2023: Lipid-lowering therapies – current and future options
Many lipid-lowering therapies exist, such as statins to manage and reduce lipid levels. While statins are the most commonly used medication, some patients may need additional interventions to lower their LDL cholesterol levels. In this touchCARDIO interview, we speak with Prof. Steven Nissen (Cleveland Clinic, Cleveland, OH, USA) to explore current and developing novel lipid-lowering […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!